Please login to the form below

Not currently logged in
Email:
Password:

Seroquel

This page shows the latest Seroquel news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca divests Seroquel rights to focus on key therapy areas

AstraZeneca divests Seroquel rights to focus on key therapy areas

AZ will continue to manufacture and supply Seroquel and Seroquel XR to Cheplapharm during a transition period. ... In 2018, Seroquel reported sales of $36m in the markets included in this agreement, while Seroquel XR generated $79m.

Latest news

More from news
Approximately 3 fully matching, plus 73 partially matching documents found.

Latest Intelligence

  • Who tops the pharma list? Who tops the pharma list?

    For example, patents for Seroquel (AstraZeneca - 2011 revenues of $5.8bn), Zyprexa (Eli Lily - $4.6bn) and Concerta (J&J - $1.3bn) had all expired by May 2012.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics